A high serum dehydroepiandrosterone concentration is a predictor of candidates for active surveillance in men with serum prostate-specific antigen < 10 ng/mL

被引：0
|
作者：
Yasuhide Miyoshi
Takashi Kawahara
Hiroji Uemura
机构：
[1] Yokohama City University Graduate School of Medicine,Department of Urology
[2] Yokohama City University Medical Center,Department of Urology and Renal Transplantation
来源：
BMC Cancer | / 22卷
关键词：
Dehydroepiandrosterone; Prostate biopsy; Gleason scores; Liquid chromatography; Biomarker; Active surveillance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A high serum dehydroepiandrosterone concentration is a predictor of candidates for active surveillance in men with serum prostate-specific antigen &lt; 10 ng/mL
    Miyoshi, Yasuhide
    Kawahara, Takashi
    Uemura, Hiroji
    [J]. BMC CANCER, 2022, 22 (01)
  • [2] Serum free prostate specific antigen as a predictor of prostate volume in men with biopsy confirmed Benign Prostatic Hyperplasia and serum total prostate specific antigen &lt; 10ng/ml
    Basillote, JB
    Rivera, AD
    Pareek, G
    Hochberg, DA
    Armenakas, NA
    Fracchia, JA
    [J]. JOURNAL OF UROLOGY, 2002, 167 (04): : 272 - 272
  • [3] The impact of prostate-specific antigen density in predicting prostate cancer when serum prostate-specific antigen levels are less than 10 ng/ml
    Akdas, A
    Tarcan, T
    Turkeri, L
    Cevik, I
    Biren, T
    Ilker, Y
    [J]. EUROPEAN UROLOGY, 1996, 29 (02) : 189 - 192
  • [4] Predictors of prostate cancer on repeat prostatic biopsy in men with serum total prostate-specific antigen between 4.1 and 10 ng/mL
    Okegawa, T
    Kinjo, M
    Ohta, M
    Miura, I
    Horie, S
    Nutahara, K
    Higashihara, E
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2003, 10 (04) : 201 - 206
  • [5] LOW SERUM DIHYDROTESTOSTERONE IS A POWERFUL PREDICTOR OF GLEASON SCORE 7-10 OF PROSTATE CANCER IN MEN WITH PROSTATE-SPECIFIC ANTIGEN LEVELS OF 3-10NG/ML
    Miyoshi, Yasuhide
    Umemoto, Susumu
    Uemura, Hiroji
    Shibata, Yasuhiro
    Honma, Seijiro
    Kubota, Yoshinobu
    [J]. JOURNAL OF UROLOGY, 2014, 191 (04): : E711 - E712
  • [6] Serum ribonuclease activity in the diagnosis of prostate cancer in men with serum prostate-specific antigen levels between 2.5 and 20 ng/mL
    Eskicorapci, SY
    Özkara, HA
    Önder, E
    Akdogan, B
    Erkan, I
    Ciliv, G
    Ozen, H
    [J]. CLINICAL BIOCHEMISTRY, 2006, 39 (04) : 363 - 366
  • [7] Percent Free Prostate-Specific Antigen (PSA) Is an Accurate Predictor of Prostate Cancer Risk in Men With Serum PSA 2.5 ng/mL and Lower
    Waiz, Jochen
    Haese, Alexander
    Scattoni, Vincenzo
    Steuber, Thomas
    Chun, Felix K. H.
    Briganti, Alberto
    Montorsi, Francesco
    Graefen, Markus
    Huland, Hartwig
    Karakiewicz, Pierre I.
    [J]. CANCER, 2008, 113 (10) : 2695 - 2703
  • [8] VARIATION OF SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS FOR MEN WITH PROSTATE CANCER MANAGED WITH ACTIVE SURVEILLANCE
    Ehdaie, Behfar
    Poon, Bing Ying
    Sjoberg, Daniel
    Vickers, Andrew
    Sternberg, Itay
    Laudone, Vincent
    Touijer, Karim
    Eastham, James
    Scardino, Peter
    [J]. JOURNAL OF UROLOGY, 2014, 191 (04): : E859 - E860
  • [9] Variation in serum prostate-specific antigen levels in men with prostate cancer managed with active surveillance
    Ehdaie, Behfar
    Poon, Bing Ying
    Sjoberg, Daniel D.
    Recabal, Pedro
    Laudone, Vincent
    Touijer, Karim
    Eastham, James
    Scardino, Peter T.
    [J]. BJU INTERNATIONAL, 2016, 118 (04) : 535 - 540
  • [10] Percent decrease of serum prostate-specific antigen after dutasteride administration is equivalent in men with clinical benign prostatic hyperplasia having baseline prostate-specific antigen &gt;10 ng/mL and those having baseline prostate-specific antigen 2.5-10 ng/mL
    Takeshita, Hideki
    Kawakami, Satoru
    Yano, Akihiro
    Okada, Yohei
    Morozumi, Makoto
    Yamada, Takumi
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (03) : 238 - 239
12345